These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Functional recovery after intravitreal bevacizumab treatments for idiopathic choroidal neovascularization in young adults. Wang F; Wang W; Yu S; Wang W; Lu F; Xu F; Hu W; Jiang Y; Wu Y; Wang H; Xu X; Sun X Retina; 2012 Apr; 32(4):679-86. PubMed ID: 22105501 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization. Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Cascavilla ML; Bandello F Retina; 2012 Sep; 32(8):1539-46. PubMed ID: 22922846 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study. Arevalo JF; Sánchez JG; Wu L; Berrocal MH; Alezzandrini AA; Restrepo N; Maia M; Farah ME; Brito M; Díaz-Llopis M; Rodríguez FJ; Reategui G; Iturralde-Iraola J; Udaondo-Mirete P; Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA; Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia. Lai TY; Chan WM; Liu DT; Lam DS Retina; 2009 Jun; 29(6):750-6. PubMed ID: 19357555 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial. Zhang H; Liu ZL; Sun P; Gu F Am J Ophthalmol; 2012 Feb; 153(2):300-306.e1. PubMed ID: 21982109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]